MacroGenics | MGNX - Pre Tax Profit

Stock Price
1.97
Daily Change
-0.01 -0.51%
Monthly
9.44%
Yearly
-19.92%
Q1 Forecast
1.65

MacroGenics reported $16.82M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Amgen USD 3.92B 2.35B Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Daiichi Sankyo JPY 106.73B 48.96B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Genmab DKK 482M 59M Sep/2025
Geron USD -31.14M 12.72M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Karyopharm Therapeutics USD -30.89M 1.16M Dec/2024
MacroGenics USD 16.82M 52.97M Sep/2025
Merck USD 6.74B 22M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Puma Biotechnology USD 20.61M 24.76M Sep/2024
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Xencor USD -4.27M 1.76M Dec/2025